These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Theoretical bases in the search for new cardiovascular agents among peptides]. Val'dman AV; Medvedev SS Vestn Akad Med Nauk SSSR; 1982; (5):14-23. PubMed ID: 7048787 [No Abstract] [Full Text] [Related]
8. [Effect of met-enkephalin on the formation and fixation of defensive temporary connections and C14-leucine incorporation into the cerebral proteins of rats]. Kruglikov RI; Gol'dberg MB; Maĭzelis MIa; Zabludovskiĭ AL Izv Akad Nauk SSSR Biol; 1980; (5):778-81. PubMed ID: 7419793 [No Abstract] [Full Text] [Related]
9. [Neuropeptide role in the etiology, pathogenesis and clinical aspects of mental diseases]. Bakharev VD; Tikhomirov SM Sov Med; 1984; (6):50-3. PubMed ID: 6147020 [No Abstract] [Full Text] [Related]
11. [Effect of Lysoneuro and its polypeptide fractions on norepinephrine and epinephrine]. Gomarasca P; D'Atri G; Galimberti E; Pedrazzini S Minerva Med; 1972 Jan; 63(2):139-57. PubMed ID: 5062108 [No Abstract] [Full Text] [Related]
12. Enkephalins increase dopamine levels in the CNS of a marine mollusc. Stefano GB; Catapane EJ Life Sci; 1979 Apr; 24(17):1617-21. PubMed ID: 481096 [No Abstract] [Full Text] [Related]
13. Cardiovascular effects of peptides related to the enkephalins and beta-casomorphin. Wei ET; Lee A; Chang JK Life Sci; 1980 May; 26(18):1517-22. PubMed ID: 7392801 [No Abstract] [Full Text] [Related]
14. Effects of enkephalins and of substance P on the hypothalamo-neuro-hypophysial system of the rat [proceedings]. Baertschi AJ; Dreifuss JJ J Physiol; 1979 Apr; 289():56P-57P. PubMed ID: 458694 [No Abstract] [Full Text] [Related]
15. Methods for evaluating effects of opioid peptides in laboratory animals. Psychopharmacol Bull; 1981 Jul; 17(3):106-11. PubMed ID: 6270718 [No Abstract] [Full Text] [Related]
16. [Endogenous opiate-like substances and cardiovascular activity (author's transl)]. Zhang F; Tang J Sheng Li Ke Xue Jin Zhan; 1980 Apr; 11(4):365-7. PubMed ID: 7256247 [No Abstract] [Full Text] [Related]
17. Neuropeptides and central catecholamine systems: interactions in neuroendocrine and central cardiovascular regulation. Fuxe K; Andersson K; Locatelli V; Mutt V; Lundberg J; Hökfelt T; Agnati LF; Eneroth P; Bolme P Adv Biochem Psychopharmacol; 1980; 22():37-50. PubMed ID: 6156580 [No Abstract] [Full Text] [Related]
18. Effects of metenkephalin on the formation and fixation of defensive temporal associations and on the incorporation of C14-leucine in brain proteins of the rat. Kruglikov RI; Gol'dberg MV; Maizelis MYa ; Zabludovskii AL Biol Bull Acad Sci USSR; 1980; 7(5):432-4. PubMed ID: 7317515 [TBL] [Abstract][Full Text] [Related]
19. [Serotoninergic 1A receptors (5-HT1A) and the regulation of blood pressure]. Dabire H Therapie; 1990; 45 Suppl 2():183-6. PubMed ID: 2339340 [No Abstract] [Full Text] [Related]
20. An overview of neuropeptides. Krieger DT Res Publ Assoc Res Nerv Ment Dis; 1986; 64():1-32. PubMed ID: 2873634 [No Abstract] [Full Text] [Related] [Next] [New Search]